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This study aimed to assess the quality of life of patients with autoimmune diseases (AID) submitted to Bone
Marrow Transplantation (BMT) at two different moments: when the patient is admitted at the hospital and at the
moment of hospital discharge (30 days after the transplantation). Patients who attended the BMT unit, were
older than 18 years, with conditions and availability to voluntarily collaborate to the study were selected. Data
were collected through a semi-structured interview and the Medical Outcomes Study 36-Item Short-Form Health
Survey (SF-36). The sample consisted of 19 patients attended at a university hospital in the interior of São
Paulo State, Brazil. The collected data suggest these patients’ quality of life is reduced before the realization of
the transplantation, followed by a progression in their diseases. Immediately after the transplantation, an
improved capacity to perform daily activities is observed, as well as a renewed possibility of making future
plans.
DESCRIPTORS: quality of life; bone marrow transplantation; autoimmune diseases; hematopoietic stem cell
transplantation
CALIDAD DE VIDA DE PACIENTES CON ENFERMEDADES AUTOINMUNES SOMETIDOS A
TRANSPLANTE DE MÉDULA ÓSEA: UN ESTUDIO LONGITUDINAL
El objetivo de este estudio fue evaluar la calidad de vida de pacientes con enfermedades auto-inmunes (EAI),
sometidos al Transplante de Médula Ósea (TMO), en dos momentos distintos: en la admisión del paciente y
durante la ocasión del alta hospitalaria (30 días después del transplante). Fueron seleccionados pacientes
atendidos en la unidad de TMO, mayores de 18 años, que presentaron condiciones y disponibilidad para
colaborar voluntariamente. Para recolectar los datos se utilizó un cuestionario de entrevista semi-estructurado
y el Cuestionario de Evaluación de Calidad de Vida - SF-36. La muestra fue compuesta por 19 pacientes
atendidos en un hospital-escuela del interior del Estado de San Pablo, Brasil. Los datos obtenidos sugieren
depreciación en la calidad de vida de esos pacientes antes de la realización del transplante, acompañada de la
progresión de sus enfermedades. Inmediatamente después del transplante ya se observa una percepción de
mejoría en la capacidad de realizar actividades del cotidiano y la posibilidad renovada de trazar planos futuros.
DESCRIPTORES: calidad de vida; trasplante de médula ósea; enfermedades autoinmunes; trasplante de células
madre hematopoyéticas
QUALIDADE DE  VIDA DE PACIENTES COM DOENÇAS AUTO-IMUNES SUBMETIDOS AO
TRANSPLANTE DE MEDULA ÓSSEA: UM ESTUDO LONGITUDINAL
O objetivo deste estudo foi avaliar a qualidade de vida de pacientes com doenças auto-imunes (DAI), submetidos
ao Transplante de Medula Óssea (TMO), em dois momentos distintos: na admissão do paciente e por ocasião
da alta hospitalar (30 dias após o transplante). Foram selecionados pacientes atendidos na unidade de TMO,
maiores de 18 anos, que apresentaram condições e disponibilidade para colaborar voluntariamente. Para a
coleta de dados utilizou-se roteiro de entrevista semi-estruturada e o Questionário de Avaliação de Qualidade
de Vida - SF-36. A amostra foi composta por 19 pacientes atendidos em um hospital-escola do interior do
Estado de São Paulo, Brasil. Os dados obtidos sugerem depreciação da qualidade de vida desses pacientes
antes da realização do transplante, acompanhada da progressão de suas enfermidades. Imediatamente após
o transplante já se percebe melhora da capacidade para realizar atividades do cotidiano e a possibilidade
renovada de traçar planos futuros.
DESCRITORES: qualidade de vida; transplante de medula óssea; doenças auto-imunes; transplante de célula-
tronco hematopoéticas
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INTRODUCTION
Autoimmune diseases (AID) constitute a
heterogeneous group of pathologies with variable
presentation and severity, treated with anti-
inflammatory drugs, immunosuppressors and
immunomodulators, with satisfactory results in the
majority of patients(1). However, advancements in the
AID pharmacobiological therapies have not prevented
that a subpopulation of patients with progressive forms
of these diseases has a bad prognosis. The low quality
and expectancy of life of these patients justify the
use of aggressive therapies like high dosage
chemotherapy, with or without bone marrow
transplantation (BMT)(2).
In this scenario, autologous BMT is presented
as a potential treatment for diseases like multiple
sclerosis(3-4), systemic lupus erythematosus(5) and type
1 diabetes mellitus(6).
Nevertheless, BMT is not a definitive solution.
It is an aggressive procedure, which can either
recover patients’ life or lead them to death. This
paradox basically occurs because the
immunosuppression induced by the pre-BMT regime
turn patients temporarily vulnerable to complications
that cause risks, not only to their physical integrity
but also to their life(7).
Because of these factors, qualify of life (QoL)
has been shown as an important criterion in the
effectiveness evaluation of certain interventions in the
health area. This study used the concept of qualify of
life related to health. It refers to the perceptions people
hold of their health, based on subjective evaluation
of their health condition and treatments they are
submitted to. To analyze the chronic impact of chronic
diseases and interventions in people’s daily life, it is
necessary to evaluate indicators of physical
functioning, social aspects, emotional and mental
state, repercussion of symptoms and individual
perception of wellbeing(8).
OBJECTIVE
This study aimed to evaluate the health-
related quality of life of patients with autoimmune
diseases who were submitted to BMT in two different
moments: when the patient is admitted to the hospital
and at discharge (around 30 days after the marrow
infusion). This evaluation aimed to: 1) understand the
meaning of quality of life for patients with AIDs through
semi-structured interviews (qualitative approach); 2)
evaluate the health-related quality of life (through SF-
36), 3) and establish connections between data
obtained through the instruments.
JUSTIFICATION
In the last decades, the scientific literature
has focused its attention on aspects of health-related
quality of life in individuals with chronic health
conditions.
Because BMT is an innovation in AID
treatments, studies aimed at evaluating not only its
technical effectiveness but also the impact it causes
on patients’ life are essential. The majority of studies
has focused only on its clinical aspect and because of
this, evaluating the emotional and psychosocial
aspects involved in the treatment of an autoimmune
disease is important.
Specifically, if adequately measured, the
health-related quality of life makes it possible to
evaluate therapeutic intervention effects, rethinking
some modalities, considering their effects on the
patient’s life in the medium and long run(9).
This study is inserted in the scenario in which
Brazil stands out as pioneer in the application of BMT
in some of these diseases and focuses on results
obtained in the Bone Marrow Transplant Unit (BMTU)
at the Hospital das Clinicas, Medical School at Ribeirão
Preto (HCFMRP) – the only public health service in
the country that performs this therapeutic.
METHOD
The quantitative method is evidenced by
previous and technical hypotheses of systematic
verification, in the search for causal explanations of
the study phenomena(10). This method aims to know
and control variables, eliminating confusing factors.
It is concerned with validity and reliability, with a view
to producing theoretical generalizations. In the health
context, this model is frequently related to
epidemiological studies, leaving concerns related to
implicit subjective factors for the human areas to
study(11).
In the context of the qualitative methodology
applied to health, the concept brought from the human
sciences is used, according to which one does not
attempt to study the phenomenon per se, but to
understand its individual or collective meaning in
people’s life. Thus, it is essential to know what the
phenomena of the disease and life in general represent
to them(12).
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This study aimed to integrate the advantages
of both the quantitative and qualitative methods. This
integration was possible through the triangulation of
data, that is, jointly applying theory and technique,
as well as establishing connections between data
obtained through the instruments used(10).
The project was approved by the service
coordination and Research Ethics Committee at the
Hospital das Clínicas, FMRP-USP (process HCRP
number 9613/2003).
The sample was composed of 19 patients with
autoimmune diseases, both genders, submitted to
BMT at the BMTU, HC-FMRP-USP. All patients who met
the inclusion criteria and were attended at the unit
between December 2003 and December 2005 were
included in the study. The selection criteria were: AID
diagnosis; ar least 18 years of age; under treatment
in pre and post BMT at the BMTU in the period
delimitated for evaluation; present conditions and
availability to voluntarialy collaborate with the
research and cognitive abilities and other basic mental
functions.
Table 1 presents a characterization of patients
who participated in the investigation according to their
sociodemographic profile.
Table 1 – Distribution of patients submitted to BMT by
the sample’s sociodemographic profile, Ribeirão Preto,
SP, 2003-2005
tnapicitraP egA latiraM sutats
-O/noisseforP
noitapucc *sisongaiD
fohtgneL
sisongaid
)sraey(
avieN 14 deirraM rehcaeT AT 31
oluaS 83 deirraM ssenisuB rotartsinimdA SM 6
sognimoD 25 deirraM reenignE SM 8
oivlíS 93 deirraM tsiparehtoisyhP P 5
oravlÁ 05 deirraM naicisyhP SM 01
atreboR 44 deirraM stnevE retomorP ELS 11
odranoeL 42 tnatibahoC retniaP D shtnom4
anavliS 24 deirraM ssenisuB nosrep SM 8
atraM 14 decroviD tnahcreM SM 01
erdnaxelA 72 deirraM gnisruN yrailixuA D shtnom3
ataneR 73 deirraM rehcaeT SM 7
odlavsO 15 deirraM suomonotuA rekrow SM 8
egnaloS 62 elgniS rotacudE P 7
alieL 03 tnatibahoC tsigoloiB SM 9
ayaroS 34 decroviD efiwesuoH SM 7
alecraM 84 deirraM yraterceS SM 01
lavreboR 45 deirraM tnahcreM SM 5
assiralC 63 deirraM yraterceS EM 7
aicíL 23 elgniS tcetihcrA EM 6
TA (Takayasu’s Arteritis); P (Pemphigus); EM (Multiple sclerosis); SLE
(Systemic Lupus Erymathosus); D (type 1 Diabetes Mellitus)
It is observed in Table 1 that, among the 19
participants, 11 were female. The sample’s average
age was 39.7 years (se= 9.04), ranging from 26 to 54
years. Patients were mostly married and had
remunerated activities that varied according to the
level of qualification and required education, while 10
participants had a higher education degree. It is also
observed that the predominant primary disease in this
sample was Multiple Sclerosis (13 patients) and that
diagnosis time varied from 3 months to 13 years
(X=7.3 years; se=3.2). All participants are referred
to by fictitious names.
The BMTU – HC-FMRP-USP was created in
1992. It is a facility with seven beds and counts on a
multiprofessional team composed of physicians,
nurses, nursing auxiliaries, social workers,
physiotherapists, nutritionists, psychologists,
occupational therapists and dental surgeons. The BMT
in AID initiated its activities in June 2001 and, on the
average, two transplantations are performed per
month.
The participation of patients in the study was
voluntary and there was no refusal. Five participants
died between 7 and 15 days after the transplantation.
Instruments
Medical Outcomes Study 36-Item Short-Form Health
Survey (SF-36)
The SF-36 is a multidimensional instrument
for generical evaluation of the perceived health state
or, as it has been called more recently, the health-
related quality of life, of easy administration and
understanding, originally created in English(13),
translated and validated in Brazil(8). It is composed of
36 items, which evaluate two components: the physical
health component (PHC) and the mental health
component (MHC). The PHC presents the following
dimensions: Physical Functioning (evaluates whether
there are physical activities and limitations); Role
Limitations due to Physical Problems (evaluates
physical limitations and how much they affect the
realization of work and daily tasks); Bodily Pain
(evaluates the extension and interference of physical
pain in daily activities); General Health Perceptions
(it refers to the subjective perception of the general
health state). The MHC is constituted of the following
dimensions: Social Functioning (evaluates how
frequently social activities are affected due to physical
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or emotional problems); Vitality (evaluates feelings of
tiredness and exhaustion and their persistence over
time); Role Limitations due to Emotional Problems
(evaluates limitations to work or perform other
activities due to emotional problems); General Mental
Health (evaluates feelings of anxiety, depression,
altered behavior, emotional lack of control and their
persistence over time). The results of each dimension
varied from 0 to 100, in which zero corresponds to the
worst health state and 100 to the best health state(8,13).
Semi-structured Interviews
Semi-structured interviews were used, based
on the researchers’ practical experience. They aimed
to characterize the subjects regarding their age,
marital status, education, occupation, length of
diagnosis and identify physical changes, as well as
changes in social relations after the appearance of
the autoimmune disease in patients’ life. This
identification is important because the SF 36 does not
permit specifying these changes. In addition, the
interview allows one to know patients’ perspectives
in relation to the BMT, expected difficulties (pre-BMT)
and those really faced (post-BMT), as well as their
expectations and future plans.
Data Collection
The instruments were applied in the pre-BMT,
upon the patients’ admission to the hospital, in the
BMTU nursing ward. Post-BMT data were collected
during follow-ups, around 30 days after the
transplantation, at the BMTU outpatient clinic or the
Support Group for Bone Marrow Transplanted
(SGBMT) Patients.
Interviews were audio recorded after
participants’ consent. A previously established
semi-structured script was followed and applied
individually and face-to-face.
Data analysis
Interviews were fully transcribed and
qualitative analysis was used, aiming to identify the
patients’ concepts, beliefs, values, motivations and
attitudes in relation to their experience with the
disease and transplantation. Thematic content analysis
was used. It consists of: pre-analysis (organization
of material and systematization of ideas); analytical
description (categorization of data in units) and
referential interpretation (treatment of data and
interpretation based on the literature)(14). The analysis
of the SF-36 results followed recommendations from
literature(8). After data collection, the data obtained
through this scale were submitted to statistical analysis.
The level of significance adopted was p£0.05. It was
initially verified whether the differences between the
moments (pre-BMT and post-BMT) presented normal
distribution through Kolmogorov-Smirnov’s test. After
the normality hipothesis was not rejected, the two
moments were then compared, aiming to detect
significant differences between the obtained data,
through Wilcoxon’s non-parametric test for paired
samples.
RESULTS
The results of 14 subjects evaluated in the
pre and post BMT phases were compared. The results
of the remaining subjects, who died, were excluded
from the analysis since the objective of the study was
to compare data obtained in the two moments of
treatment.
Health-related quality of life
The average results from the SF-36 scale in
the evaluation of the pre and post transplantation
stages were systematized in Table 2.
tnenopmoC
stnemoM
TMB-ERP TMB-TSOP
egarevA ES egarevA ES *p
tnenopmoClacisyhP
gninoitcnuFlacisyhP 92.42 29.13 41.23 75.43 90.0
smelborPlacisyhPoteudsnoitatimiLeloR 12.32 39.42 63.03 06.53 45.0
niaPylidoB 92.76 35.82 00.26 44.92 24.0
snoitpecrePhtlaeHlareneG 41.76 30.02 75.17 90.51 14.0
tnenopmoClatneM
ytilatiV 41.76 88.91 92.95 95.81 42.0
gninoitcnuFlaicoS 52.46 59.82 93.36 14.03 97.0
smelborPlanoitomEoteudsnoitatimiLeloR 05.95 66.54 75.95 47.34 88.0
htlaeHlatneMlareneG 00.67 80.72 17.17 46.61 04.0
Table 2 – Average results obtained through the application of SF-36 in the sample of patients who survived the
BMT. Ribeirão Preto, SP, 2003-2005
* p≤0.05
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According to the statistical analysis, there was
no significant alteration in any of the quality of life
components evaluated by this instrument. On the other
hand, the level of significance in the Physical
Functioning component is close to the adopted
(p≤0.05), which shows a tendency of significantly
higher post BMT than pre BMT values.
Pre BMT interview
The analysis of interviews revealed not only
aspects of these patients’ history of life, but also
difficulties they have faced over many years of
experience with chronic diseases and their progressive
and disabling course.
Interviews carried out in the pre
transplantation phase allowed researchers to obtain
data on the participants’ life history, experience with
the disease and expectations regarding the BMT.
Long experience with the disease and
dependency on health services: Among the 14 patients
who survived the BMT, 12 had been diagnosed quite
some time ago. They had already experienced several
treatments and a long peregrination through health
services. In some cases, no treatment had achieved
the desired effect. It was noticed that these patients
invariably reached the transplantation reporting
tiredness after successive unsuccessful treatment
attempts: The decision was to try all immunosupressors
and they didn’t work anymore. I’d have pain all the time,
never woke up or opened my eyes without pain. So the pain,
is like, my constant companion? No! I think like, it’s an
aggressive treatment? Yeah! Unfortunately, for the good cells
too. But the disease is very aggressive, so we’ll have to use
heavy weapons. (Neiva, 41)
Routine limitations and change of life: The
disease for these patients is a factor that triggered
several changes in their lives. So, difficulties emerge
in the performance of daily tasks. Limitations due to
progressive loss of abilities make them give up their
professional activity because they are not able to
anymore, or even retire early. From the psychological
point of view, discouragement and negative feelings
gradually escalate and are intensified by dependency
on other people to perform daily tasks. On the other
hand, in some cases, the disease appears as an
opportunity to reflect on life, leading to a re-evaluation
of beliefs and values and to a more accurate
perception of their human condition: It helped to face it
more easily, with less fear. I was afraid of everything. Today I’m
self sure. I used to be a person who’d not go anywhere ‘cause I’d
get sick, I’d stumble. Now, I have my difficulties, so I have to
adapt to take care of my problems. (Soraya, 43)
Some reports related to the occurred changes
deserve to be highlighted in the analysis of the
interviews. All patients report profound changes in
their daily routine with gradual aggravation of the
disease: Today, because of this physical aspect, I’m very
dependent on everything, you know? For little things, like getting
a glass of water, and dependency for major things like taking a
shower, see? So, I see myself, sometimes, really upset, more
anxious, more annoying, more irritated, just because I can’t do
things by myself. (Álvaro, 50)
In fact, the most noticeable changes are the
physical and bodily changes. However, the perception
of change, many times subtle, in their life style and
on how they relate with themselves, with the world
and people, as well as the way they deal with
problems, were also recurrent in their reports: I’m
learning how to deal with my limitations. Everyday I have to
learn a little, because the disease progresses a little everyday.
As I told you before, driving was an automatic thing and I haven’t
driven for more than two years now, so I’m adapting, you know?
(Roberval, 54)
Family reorganization: With respect to the
potential changes perceived in the interaction with
family and friends, three aspects can be highlighted,
as follows:
- The perception that the family has joined after the
disease: The family started to get a little closer. They started
to pay more attention to my things. So, I guess it is… well, good,
beneficial, because it is something that… if it weren’t the disease,
maybe I’d have to reprehend them for something. (Álvaro, 50)
- The perception that friends got distant: Many people
got away from me. In the beginning it’d hurt and I’d cry. I used
to be around lots of people when I got worse. I thought like:
Wow! Now that I can’t work anymore people will come and see
me, they’ll call to know about me. And that didn’t happen. So, in
the beginning it surprised me a lot. Then, I understood that each
person reacts in a different way and who ended up by my side
were people I really was closer to. (Neiva, 41)
- The perception that the patient distanced him(er)self
from family and friends: I got more retired, I don’t want to
get close to people, think they’ll have prejudice, I don’t know. I
ran away, but it’s all in my head. (Lícia, 32)
Changing the project of life: In this context
with so many losses, for patients, stem cell
transplantation entails an expectation of recovering
the life they had before the disease and resume their
plans and project of life they had left behind. Although
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many of these patients are aware that the procedure
is not a promise of cure, but an attempt to interrupt
the progressive course of the disease. They affirm
that they will be satisfied if they can achieve this goal.
Their reports implicitly - and sometimes explicitly –
contain the hope that this innovating treatment will
be the definitive answer to their problems: I want a new
life! Better quality of life! If my hair will grow again or not, it’s up
to destiny. If Im going to get a big belly or not, it’s up to time.
But I’ll tell you, I’ll be happy with my family. I think this is the
least you can do! (Saulo, 38)
Post BMT Interview
 Redimensioning their expectations: The
analysis of the post transplantation interviews point
to an intense involvement of patients in the
redimensioning of their own expectations with regard
to the procedure result. In this perspective, some
show a perception of improvement, others feel
frustrated about the maintenance of their previous
physical condtion: 1a) I have noticed here in my legs…
Before, I didn’t have the strength, I’d fall. Now I manage to
stand! And my spine also, it had a tendency to bend, and now
it doesn’t. Only when I’m too tired or the weather is too hot
(Soraya, 43); 1b) It’s difficult to see any improvement,
you know? Because my legs still hurt a lot, but… It’s a
treatment I didn’t think would take this long, you know? I
wasn’t prepared for this. (Silvana, 42)
 Continuation of limitations: The dependency
on others to perform simple daily tasks stood out not
only in the post BMT interviews, but also in the
interviews carried out before the transplantation. This
was one of the most inconvenient factors mentioned
by the study participants, which is still limiting their
lives post BMT: What bothers me most is the possibility of
being a burden to others. It bothers me a lot. And people
getting trapped with my problem. It makes me very upset.
(Roberval, 54)
 Devising the future: In relation to future
expectations, all patients report the expectation of
improvement. They actually nourished the desire that
the treatment would really cure them and allow them
to resume their lives from where it had been
interrupted: I’m not someone who wants to be in bed all day,
expecting people will feed me… I’m not going to try to kill myself
because of this, but I think I still have potential to do a lot, so…I
thought it wouldn’t hurt to lose movements, but I was ok then.
Now my mind is faulting, so let’s start moving because it’s not
working this way (anxious laugh). (Silvana, 42)
DISCUSSION
In general, retrospection suggests these
patients’ quality of life is continuously and constantly
reduced as the disease insidiously progresses. In this
devastating scenario, the transplant is presented as
a heroic possibility, so that they would recover not
only their movements but also the normal life they
had lost.
In summary, in the immediate post BMT,
despite the relief they felt for leaving the nursing ward
and the hospital environment, their quality of life
seemed to be harmed in several aspects.
In the SF-36 evaluation, data suggest
patients have a perception of improvement after
the procedure in relation to the capacity to perform
daily tasks.
It could be perceived in the data analysis that
patients presented a good psychosocial adaptation
before the disease, that they had a productive life
and satisfactory performed their social roles,
professional activities and daily life. They were mostly
people with good or at least average cultural and
economic level, which shows, from the evolutive point
of view, that they were autonomous, able to make
their own decisions and execute tasks according to
what is expected from adult people. In this context,
the loss of their health condition led to harmed
adaptative capacity and daily organization, coupled
to a faulty social support network, leading to feelings
of deception, anger, denial and frustation, which put
people face-to-face with their own weakness in the
face of adverse events, which they cannot control.
Despite the marking difficulties caused by the
disease, they show ability to overcome challenges,
common daily preocupations caused by the disease
and preservation of affective involvement with
family and friends.
The disease implied a broad range of
symptoms that progressively aggravates. It can be
perceived that the main complaints are related to the
loss of physical functioning, which prevents them from
exerting their routines with the same ability and
dedication they were used to. In this sense, the
perception of difficulties and limitations in simple daily
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tasks, the impossibility of continuing to exert their
regular professional activity, exposure to continuous
pain and perceived changes in their interpersonal
relationships are highlighted.
On the other hand, new possibilities are
noticed, as they reflect on the meaning of their lives,
values, beliefs and projects. Thus, the diagnosis of
an autoimmune disease, despite the hope for cure
expressed by some patients, substantially interferes
in their quality of life. In this study, it appears harmed,
especially in the Physical Functioning and Role
Limitations due to Physical Problems. Differently from
what is appointed in literature(15), in this study, patients
showed themselves very determined regarding the
transplantation, always characterizing it as a salvation-
treatment and disconsidering the equally viable
possibility of threat-treatment. It can be due to
the fact that these patients have lived with their
diseases for a very long time, have suffered a
considerable reduction in their quality of life as a
consequence of the disease progression, and have
already tr ied several  treatments with no
satisfactory results. And especially because they
felt they were at the limit of their strength, nearing
physical and mental exhaustion, which makes them
reveal they are very “tired” of feeling so many
limitations in their lives.
Therefore, the transplantation appears as a
redemptive possibility, a hope for cure, and for
recovery of their so compromised quality of life,
corroborating with findings of some authors(16), who
appoint that this expectation encourages them to
decide in favor of the BMT.
When patients leave the nursing ward after
transplantation, they present indices of quality of life
very similar to those they had previously to the
surgery, so there is no significant statistical difference
between the two phases of the procedure. This result
per se can be seen as positive if we consider the
BMT’s tremendous consequences. Nevertheless, the
data obtained through interviews analysis appoint to
a perception of improvement of Role Limitations due
to Physical Problems and Physical Functioning right
after the hospital discharge. The majority of patients
showed renewed disposition to perform daily activities,
even against medical recommendations, which
indicates improved emotional state. Thus, despite
feelings of weakness and frustration experienced
by patients with autoimmune diseases, there is a
possibility that patients will feel capable of dealing
with challenges and overcoming adverse conditions,
seeking not to restrict themselves to the limitations
of the chronic condition, which is experienced as
feelings of capability and power in the face of
life(17).
A fact to be considered when one refers to
quality of life of these patients is the change in life
styles. Patients recover quality of life previous to the
procedure, but not the same quality of life, and
changes like better appreciation of life and search for
closer affective interpersonal relationships(18) are
common. These changes could be verified through
interviews, in which the majority appointed their own
life as the most precious thing.
CONCLUSIONS
It can be concluded that, when applied as a
therapeutic technique for autoimmune diseases, after
leaving hospital, BMT contributes to a perception of
improved capacity to perform everyday activities.
Patients feel encouraged by the possibility of
reorganizing their professional life, resuming their
plans and reliving their dreams interrupted for so long
because of the disease.
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